"AI New Drug Development Information at a Glance"… Jevahyup AI Center Opens 'KAICD'

‘Artificial Intelligence New Drug Development Information Portal (KAICD)’ homepage (Photo by Korea Pharmaceutical and Bio-Pharma Manufacturers Association AI New Drug Development Support Center)

[Asia Economy Reporter Lee Chun-hee] The Korea Pharmaceutical and Bio-Pharma Manufacturers Association's Artificial Intelligence New Drug Development Support Center (AI Center) announced on the 17th that it has launched and is operating the ‘AI New Drug Development Information Platform (KAICD)’.

The AI Center explained that although AI-based new drug development by pharmaceutical and bio companies has increased, the information available is insufficient and scattered, making it difficult to collect data tailored to their needs. To improve this, they established the KAICD platform to aggregate AI-related information.

KAICD consists of ▲Notifications & News ▲Company Information ▲Network ▲Library ▲AI New Drug Development Support Center. As of today, it comprehensively includes over 150 domestic and international articles related to AI new drug development, about 30 video materials, 30 job postings, and information on 30 AI new drug development companies and research institutes.

It also provides information on the technologies held by AI new drug development companies, investments, and joint research. These materials are regularly posted directly by companies and managed by the center. Through this, it is expected to become a collaborative space for pharmaceutical companies needing AI new drug development technology and AI new drug development companies.

An AI Center official stated, “KAICD is the center’s official website containing everything related to AI new drug development, including company promotion and information sharing,” adding, “The number of mutual collaboration matchings (open innovation services) where AI new drug development companies and pharmaceutical companies cooperate to develop new AI drugs will increase.” The AI Center plans to expand the mutual collaboration matching service online next year and implement it in full scale.

This content was produced with the assistance of AI translation services.